RSCF (Reflect Scientific) Beneish M-Score: -2.70 (As of Jun. 24, 2026)

What is Reflect Scientific Beneish M-Score?

Reflect Scientific RSCF Beneish M-Score is -2.70 as of Jun. 24, 2026. The stock has 4 warning signs investors should review. Among 765 Medical Devices & Instruments companies, Reflect Scientific ranks better than 60.39% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.7 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Reflect Scientific's Beneish M-Score or its related term are showing as below:

RSCF' s Beneish M-Score Range Over the Past 10 Years
Min: -7.98 Med: -3.97 Max: 2.85
Current: -2.7

During the past 13 years, the highest Beneish M-Score of Reflect Scientific was 2.85. The lowest was -7.98. And the median was -3.97.

Reflect Scientific Beneish M-Score Related Terms

Reflect Scientific Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Reflect Scientific's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Reflect Scientific Beneish M-Score Chart

Reflect Scientific Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Beneish M-Score

Get a 7-Day Free Trial

-6.01

2.03

-2.89

-2.23

-4.20

Reflect Scientific Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Jun25	Sep25
Beneish M-Score	Get a 7-Day Free Trial															-2.21	-1.46	-0.84	-0.87	-2.70

RSCF vs GCTK, CBSC, NXGL: Beneish M-Score Comparison

For the Medical Instruments & Supplies subindustry, Reflect Scientific's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Reflect Scientific Beneish M-Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Reflect Scientific's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Reflect Scientific's Beneish M-Score falls into.

Save Embed

Reflect Scientific Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Reflect Scientific for today is based on a combination of the following eight different indices:

-4.84

0.92 * DSRI

0.528 * GMI

0.404 * AQI

0.892 * SGI

0.115 * DEPI

-4.84

0.92 * 0.5177

0.528 * 0.9127

0.404 * 0.9354

0.892 * 1.4069

0.115 * 0.6447

0.172 * SGAI

4.679 * TATA

0.327 * LVGI

0.172 * 0.5891

4.679 * -0.034242

0.327 * 0.8127

-2.70

This Year (Sep25) TTM:

Last Year (Mar24) TTM:

Total Receivables was $0.24 Mil.
Revenue was 0.4 + 0.28 + 0.514 + 0.59 = $1.78 Mil.
Gross Profit was 0.229 + 0.18 + 0.328 + 0.359 = $1.10 Mil.
Total Current Assets was $2.70 Mil.
Total Assets was $2.86 Mil.
Property, Plant and Equipment(Net PPE) was $0.10 Mil.
Depreciation, Depletion and Amortization(DDA) was $0.06 Mil.
Selling, General, & Admin. Expense(SGA) was $0.86 Mil.
Total Current Liabilities was $0.69 Mil.
Long-Term Debt & Capital Lease Obligation was $0.02 Mil.
Net Income was 0.041 + -0.006 + 0.11 + 0.109 = $0.25 Mil.
Non Operating Income was 0.011 + 0.01 + 0.011 + 0.011 = $0.04 Mil.
Cash Flow from Operations was 0.378 + 0 + -0.072 + 0.003 = $0.31 Mil.

Total Receivables was $0.34 Mil.
Revenue was 0.429 + 0.189 + 0.526 + 0.124 = $1.27 Mil.
Gross Profit was 0.242 + 0.078 + 0.33 + 0.061 = $0.71 Mil.
Total Current Assets was $2.40 Mil.
Total Assets was $2.68 Mil.
Property, Plant and Equipment(Net PPE) was $0.22 Mil.
Depreciation, Depletion and Amortization(DDA) was $0.07 Mil.
Selling, General, & Admin. Expense(SGA) was $1.04 Mil.
Total Current Liabilities was $0.66 Mil.
Long-Term Debt & Capital Lease Obligation was $0.16 Mil.

1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI	=	(Receivables_t / Revenue_t)	/	(Receivables_t-1 / Revenue_t-1)
	=	(0.244 / 1.784)	/	(0.335 / 1.268)
	=	0.136771	/	0.264196
	=	0.5177

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI	=	GrossMargin_t-1	/	GrossMargin_t
	=	(GrossProfit_t-1 / Revenue_t-1)	/	(GrossProfit_t / Revenue_t)
	=	(0.711 / 1.268)	/	(1.096 / 1.784)
	=	0.560726	/	0.61435
	=	0.9127

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI	=	(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t)	/	(1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
	=	(1 - (2.696 + 0.103) / 2.862)	/	(1 - (2.396 + 0.218) / 2.677)
	=	0.022013	/	0.023534
	=	0.9354

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI	=	Sales_t	/	Sales_t-1
	=	Revenue_t	/	Revenue_t-1
	=	1.784	/	1.268
	=	1.4069

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI	=	(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1))	/	(Depreciation_t / (Depreciaton_t + PPE_t))
	=	(0.065 / (0.065 + 0.218))	/	(0.057 / (0.057 + 0.103))
	=	0.229682	/	0.35625
	=	0.6447

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI	=	(SGA_t / Sales_t)	/	(SGA_t-1 /Sales_t-1)
	=	(0.862 / 1.784)	/	(1.04 / 1.268)
	=	0.483184	/	0.820189
	=	0.5891

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI	=	((LTD_t + CurrentLiabilities_t) / TotalAssets_t)	/	((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
	=	((0.019 + 0.69) / 2.862)	/	((0.161 + 0.655) / 2.677)
	=	0.247729	/	0.304819
	=	0.8127

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA	=	(IncomefromContinuingOperations_t	-	CashFlowsfromOperations_t)	/	TotalAssets_t
	=	(NetIncome_t - NonOperatingIncome_t	-	CashFlowsfromOperations_t)	/	TotalAssets_t
	=	(0.254 - 0.043	-	0.309)	/	2.862
	=	-0.034242

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Reflect Scientific has a M-score of -2.70 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →

What does a Beneish M-Score of -2.70 mean?

Reflect Scientific (RSCF) has a Beneish M-Score of -2.70 as of Jun. 24, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Reflect Scientific and its competitors. According to the industry distribution chart, Reflect Scientific ranks #303 out of 765 companies in the Medical Devices & Instruments industry, placing it in the top 39.6%.

Is Reflect Scientific's Beneish M-Score too high?

Reflect Scientific's current Beneish M-Score is -2.70. Based on the distribution chart, Reflect Scientific ranks #303 out of 765 companies in the Medical Devices & Instruments industry, which is above the industry midpoint.

How does Reflect Scientific's Beneish M-Score compare to GCTK and CBSC?

According to the Medical Devices & Instruments industry distribution chart, Reflect Scientific ranks #303 out of 765 companies for Beneish M-Score. This puts Reflect Scientific in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Beneish M-Score for a Medical Devices & Instruments company?

A good Beneish M-Score depends on the Medical Devices & Instruments industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Beneish M-Score mean?

A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Reflect Scientific and its competitors. Reflect Scientific's current Beneish M-Score is -2.70. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Reflect Scientific stock overvalued right now?

Reflect Scientific (RSCF) has a current Beneish M-Score of -2.70. The current Beneish M-Score is -2.70. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Beneish M-Score calculated?

Beneish M-Score is calculated from a company's financial statements. For Reflect Scientific (RSCF), the current Beneish M-Score is -2.70 as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Reflect Scientific Business Description

Industry Healthcare Medical Devices & Instruments

Comparable Companies GCTK CBSC NXGL CUPR LUCY YBGJ MHUAF ECIA RGNT BNGO ISRG XPAR:EL TSE:7741 BDX XSWX:ALC MDLN RMD WST TSE:4543 XPAR:DIM

Address 1266 South 1380 West, Orem, UT, USA, 84058

Website https://www.reflectscientific.com

Reflect Scientific Inc is engaged in the manufacture and distribution of products targeted at the life science market. The group's customers include hospitals, diagnostic laboratories, pharmaceutical and biotech companies, cold chain management, universities, government and private sector research facilities, and chemical and industrial companies. Its growing product portfolio includes ultra-low temperature freezers, blast freezers, solvent chillers, and refrigerated transportation in addition to supplying OEM products to the life sciences industry. The group's products are Cryometrix, GCFerrules, and Visacon. It recognizes revenue from the sale of scientific equipment for the life sciences and manufacturing industries.